Timeplast, Inc.
Regulation A+ Tier 2 offering via DealMaker Securities · Form 1-A filed October 9, 2026 · Winter Springs, Florida
Timeplast, Inc., a Delaware corporation formed in Florida in 2013, develops and manufactures water-soluble pelletized resins, 3D printing filaments and the Pabyss depolymerization reactor, and sells mainly filaments directly to consumers. The company has early revenue of $171,108 for fiscal 2025 and an accumulated deficit of $7,041,682, and is offering up to 6,088,457 shares of common stock at $4.93 per share on a best-efforts basis, with an aggregate offering value of about $30.7 million.
Profile details below were extracted automatically from the issuer's offering circular and exhibits. Terms, financials and the service provider table come directly from the SEC's structured Part I data of Form 1-A.
Offering terms
- Security
- Equity (common or preferred stock)
- Tier
- Tier 2
- Maximum aggregate offering
- $30,668,239
- Price per security
- $4.93
- Securities offered
- 6,065,865
- Securities outstanding
- 48,157,467
- Offered by issuer
- $30,221,369
- Offered by selling holders
- $446,870
- Estimated net proceeds
- $28,331,158
- Offering type
- Continuous or delayed offering; best efforts
- Financial statements
- Audited, Set Apart Accountancy Corp.
- Underwriter / broker-dealer
- Dealmaker Securities, LLC
Broker-dealer, CRD 315324 - Qualification date
- Not yet qualified
- Status
- Filed
- Testing the waters
- Yes
- Offered in
- 52 states
Fees and service providers in Part I
| Role | Firm | Fee |
|---|---|---|
| Underwriter | Dealmaker Securities, LLC | $608,817 |
| Sales commissions | Dealmaker Securities, LLC | $1,179,645 |
| Auditor | Set Apart Accountancy Corp. | $21,750 |
| Legal counsel | CrowdCheck | $65,000 |
| Blue sky | Various State Fees | $15,000 |
As named in the Part I summary of the Form 1-A (item 5). Fees are anticipated amounts for the offering as filed.
Financials as filed
| Item | Most recent fiscal year |
|---|---|
| Revenue | $171,108 |
| Cost and expenses applicable to revenue | $141,866 |
| Depreciation and amortization | $38,757 |
| Net income (loss) | -$2,779,776 |
| Earnings (loss) per share, basic | -0.06 |
| Earnings (loss) per share, diluted | -0.06 |
| Total assets | $2,204,142 |
| Cash and equivalents | $1,291,507 |
| Investment securities | $0 |
| Accounts receivable | $0 |
| Property, plant and equipment | $155,059 |
| Accounts payable | $196,763 |
| Long-term debt | $0 |
| Total liabilities | $307,327 |
| Total stockholders' equity | $1,896,815 |
One fiscal year as reported in Part I of Form 1-A. 8 employees (5 full time, 3 part time).
Securities outstanding
| Class | Type | Outstanding |
|---|---|---|
| Common Stock | Common equity | 48,157,467 |
Unregistered securities issued in the last three years
| Security | Amount issued | To principal holders | Consideration |
|---|---|---|---|
| Common Stock | 2,799,507 | 0 | $4,849,873.36, representing $1.89 per share of Common Stock, not including issuance of bonus shares, and including a 3% transaction fee. |
Exemption relied on: Regulation Crowdfunding.
Use of proceeds
At $5,000,000 raised: research and development $2,050,727 (45%), scaling operations and market expansion $1,139,293 (25%), payroll $911,434 (20%), working capital $455,717 (10%); net proceeds $4,557,171 after underwriting commissions of $442,829. At $15,000,000: research and development $6,295,204 (45%), scaling operations $3,497,335 (25%), payroll $2,797,868 (20%), working capital $1,398,934 (10%); net $13,989,342. At $25,003,949: research and development $10,444,992 (45%), scaling operations $5,902,773 (25%), payroll $4,642,219 (20%), working capital $2,321,109 (10%); net $23,211,094. Working capital includes broker fees and other offering expenses (estimated $146,750). No proceeds to repay accrued CEO payroll, which the CEO has waived.
Valuation
Cash shares priced at $4.93 per share plus a 3.0% Processing Fee ($5.0779 per share including fee). Bonus Shares of 0% to 17.5% of cash shares purchased, which the company states lowers the effective price to $4.1957 per share at the maximum bonus. Company board bylaws reference a current valuation of $40,000,000 for certain approval thresholds. Pre-offering shares outstanding 48,157,467.
Prior raises
Prior Regulation CF offerings: a 2022-2023 offering sold 5,357,960 shares and a 2024-2025 offering sold 2,799,507 shares, with investors granting proxies to the CEO. Common stock issued for cash of $365,643 in 2024 (290,986 shares) and $4,272,512 in 2025 (2,509,859 shares). A $500,000 convertible note was repaid in 2024. A stockholder litigation settlement required a $60,000 payment (paid).
Financial statements
Audited. Financial statements for fiscal years ended December 31, 2025 and 2024 were audited by SetApart Accountancy Corp. (Calabasas, California), with an unmodified opinion that includes a material uncertainty paragraph on going concern.